Histocell
PrivateLast Round
Corporate Funding
Dec 12, 2022
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Histocell is a biotechnology company that develops and manufactures cell therapy products, biological medicinal products, and innovative medical devices for regenerative medicine.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Histocell Comparables
Compare Histocell with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Stemmatters, Biotecnologia e Medicina Regenerativa S.A. | 91% | |
| Cell-Easy | 86% | |
| eXmoor Pharma | 84% |
Histocell Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Corporate Funding | Dec 12, 2022 | ||||
| Corporate Funding | Nov 24, 2022 | ||||
| VC Round | Sep 14, 2018 | ||||
| VC Round | Sep 30, 2016 | ||||
| VC Round | Apr 1, 2015 |
Key People
Founding team and executive leadership
Histocell Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Seed Capital Bizkaia | VC Round |
| Gestión de Capital Riesgo del País Vasco - Grupo SPRI | VC Round |
| Orza | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 33% MoM.
- Jul 25, 2026
Monthly visitors grew 202% MoM, reaching 1.7K.
Histocell Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Histocell's valuation, stock price, and market status.
Is Histocell a public or private company?
Histocell is a private company.
What is the current stock price of Histocell?
Histocell is a private company with no public stock price. No recent secondary market data is available.
How much is Histocell worth (valuation)?
Valuation information for Histocell is not publicly available.
Can I buy Histocell stock?
Histocell shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Histocell's last funding round?
Histocell's most recent funding round was Corporate Funding on December 12, 2022.
Who are the main investors in Histocell?
Key investors in Histocell include Seed Capital Bizkaia, Gestión de Capital Riesgo del País Vasco - Grupo SPRI, Orza.
Will Histocell IPO soon?
No public IPO plans have been announced for Histocell.
How can I track Histocell secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Histocell's secondary market activity and sign up for updates.